1 |
Abbas S, Nieters A, Linseisen J, et al (2008). Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk. Breast Cancer Res, 10, 31.
|
2 |
Alimirah F, Peng X, Murillo G, et al (2011). Functional significance of vitamin D receptor FokI polymorphism in human breast cancer cells. PLoS One, 6, 16024.
DOI
|
3 |
Banerjee P, Chatterjee M (2003). Antiproliferative role of vitamin D and its analogs - a brief overview. Mol Cell Biochem, 253, 247-54.
DOI
|
4 |
Barroso E, Fernandez LP, Milne RL, et al (2008). Genetic analysis of the vitamin D receptor gene in two epithelial cancers: melanoma and breast cancer case-control studies. BMC Cancer, 8, 385
DOI
|
5 |
Bhanushali AA, Lajpal N, Das BR, et al (2009). Frequency of fokI and taqI polymorphism of vitamin D receptor gene in Indian population and its association with 25hydroxyvitamin D levels. Indian J Hum Genet, 15, 108-113.
DOI
|
6 |
Bhurgri Y, Bhurgri A, Nishter S, et al (2006). Pakistan - country profile of cancer and cancer control, 1995-2004. J Pak Med Assoc, 56, 124-30.
|
7 |
Bid H K, Mittal R D (2003). Study of vitamin-D receptor (VDR) gene start codon polymorphism (Fok I) in healthy individuals from North India. Indian J Hum Genet, 9, 51-4.
|
8 |
Breast cancer incidence statistics Cancer Research UK [Online].
|
9 |
Bretherton WD, Given WR, Mansi JL, et al (2001). Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian population. Br J Cancer, 85, 171-5.
DOI
|
10 |
Buyru N, Tezol A, Yosunkaya-Fenerci E, et al (2003). Vitamin D receptor gene polymorphisms in breast cancer. Exp Mol Med, 35, 550-5.
DOI
|
11 |
Chakraborty A, Mishra AK, Soni A, et al (2009). Vitamin D receptor gene polymorphism(s) and breast cancer risk in north Indians. Cancer Detect Prev, 32, 386-94.
DOI
|
12 |
Chen WY, Bertone-Johnson ER., Hunter DJ, et al (2005). Associations between polymorphisms in the vitamin D receptor and breast cancer risk. Cancer Epidemiol. Biomarkers Prev, 14, 2335-9.
DOI
|
13 |
Collins ES, Guyer MS, Chakravarti A, et al (1997). Variations on a theme; cataloging human DNA sequence variation. Science, 278, 1580-1.
DOI
|
14 |
Curran JE, Vaughan T, Lea RA, et al (1999). Association of A vitamin D receptor polymorphism with sporadic breast cancer development. Int J Cancer, 83, 723-726.
DOI
|
15 |
Dalessandri KM, Mike R, Wiencke JK, et al (2011). Vitamin D receptor polymorphisms and breast cancer risk in a highincidence population: a pilot study. J Am Coll Surg, 215, 652-7.
|
16 |
Ditsch N, Toth B, Mayr D, et al (2012). The Association between Vitamin D Receptor Expression and Prolonged Overall Survival in Breast Cancer. Journal of Histochemistry & Cytochemistry, 60(2), 121-129
DOI
|
17 |
Du Y, Hu L, Kong F, et al (2014). Lack of association between vitamin D receptor gene BsmI polymorphism and breast cancer risk: an updated meta-analysis involving 23,020 subjects. Tumor Biol, 35, 2087-93.
DOI
|
18 |
Engel LS, Orlow I, Sima CS, et al (2012). Vitamin D receptor gene haplotypes and polymorphisms and risk of breast cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev, 21, 1856-67.
DOI
|
19 |
Fuhrman BJ, Freedman DM, Bhatti P, et al (2013). Sunlight, Polymorphisms of Vitamin D-related Genes and Risk of Breast Cancer. Anticancer Res, 33, 543-51.
|
20 |
Giovannucci E (2005). The epidemiology of vitamin D and cancer incidence and mortality: a review. Cancer Causes Control, 16, 83-95.
DOI
|
21 |
Gombart AF, Luong QT, Koeffler HP, et al (2006). Vitamin D compounds activity against microbes and cancer. Anticancer Res, 26, 2531-42.
|
22 |
Guy M, Lowe LC, Bretherton-Watt D, et al (2004). Vitamin D receptor gene polymorphisms and breast cancer risk. Clin Cancer Res, 10, 5472-81.
DOI
|
23 |
Hou MF, Tien YC, Lin GT, et al (2002). Association of vitamin D receptor gene polymorphism with sporadic breast cancer in Taiwanese patients. Breast Cancer Res Treat, 74, 1-7.
DOI
|
24 |
Huang YZ, Lu H, Bai YH, et al (2012). Relationship between genotypes and halpotypes of vitamin d receptor gene and breast cancer risk. J Med Res, 41, 89-92.
|
25 |
Ingles SA, Garcia DG, Wang W, et al (2000). Vitamin D receptor genotype and breast cancer in Latinas (United States). Cancer Causes Control, 11, 25-30.
DOI
|
26 |
Iqbal MuN, Khan TA, Maqbool SA (2015). Vitamin d receptor cdx-2 polymorphism and premenopausal breast cancer risk in southern pakistani patients. PLoS ONE, 10, 122657.
|
27 |
Jinjiang Xu, Hongyu Li , Lixue Gu, et al (2014). Association between vitamin D receptor poly(A) polymorphism and breast cancer risk: a meta-analysis. Tumor Biol, 35, 589-93.
DOI
|
28 |
John EM, Schwartz GG, Koo J, et al (2007). Sun exposure, vitamin D receptor gene polymorphisms, and breast cancer risk in a multiethnic population. Am J Epidemiol, 166, 1409-19.
DOI
|
29 |
Khan MI, Bielecka FZ, Najm ZM, et al (2014). Vitamin D receptor gene polymorphisms in breast and renal cancer. current state and future approaches (Review). Int J Oncol, 44, 349-63.
DOI
|
30 |
Kostner K, Denzeri N, Cornelia SL, et al (2009). The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res, 29, 3511-36.
|
31 |
Lowe LC, Guy M, Mansi JL, et al (2005). Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. Eur J Cancer, 41, 1164-9.
DOI
|
32 |
McCullough ML, Bostick RM, Mayo TL, et al (2009). Vitamin D gene pathway polymorphisms and risk of colorectal, breast, and prostate cancer. Annu Rev Nutr, 29, 111-32.
DOI
|
33 |
McKay JD, Mc Cullough ML, Ziegler RG, et al (2009). Vitamin d receptor polymorphisms and breast cancer risk: results from the national cancer institute breast and prostate cancer cohort consortium. Cancer Epidemio Biomarkers Prev, 18, 297-305.
DOI
|
34 |
Mishra DK, Wu Y, Sarkissyan M, et al (2013). Vitamin d receptor gene polymorphisms and prognosis of breast cancer among african-american and hispanic women. PLoS ONE, 8, 57967.
DOI
|
35 |
Naveed S, Kamal A, Shamshad D, et al (2014). Frequency and Risk Factors of Breast Cancer in Karachi, Pakistan. Int J Med Sciences (DHR-IJMS), 5, 52-60.
|
36 |
Norman AW (2008). From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr, 88, 491-9.
DOI
|
37 |
Perna L, Butterbach K, Haug U, et al (2013). Vitamin D receptor genotype rs731236 (Taq1) and breast cancer prognosis. Cancer Epidemiol Biomarkers Prev, 22, 437-42.
DOI
|
38 |
Raimondi S, Johansson H1, Maisonneuve P, et al (2009). Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Carcinogenesis, 30, 1170-80.
DOI
|
39 |
Rollison DE, Cole AL, Tung KH, et al (2011). Vitamin D intake,vitamin D receptor polymorphisms, and breast cancer risk among women living in the southwestern U.S. Breast Cancer Res Treat, 132, 683-91.
|
40 |
Shahbazi S, Alavi S, Majidzadeh A K, et al (2013). BsmI but not FokI polymorphism of VDR gene is contributed in breast cancer. Med Oncol, 30, 393.
DOI
|
41 |
Sillanpaa P, Hirvonen A, Kataja V, et al (2004). Vitamin D receptor gene polymorphism as an important modifier of positive family history related breast cancer risk. Pharmacogenetics, 14, 239-45.
DOI
|
42 |
Silvagno F, De Vivo E, Attanasio A, et al (2010). Mitochondrial localization of vitamin D receptor in human platelets and differentiated megakaryocytes. PLoS ONE, 5, 8670.
DOI
|
43 |
Sinotte M, Rousseau F, Ayotte P, et al (2008). Vitamin D receptor polymorphisms (FokI, BsmI) and breast cancer risk: association replication in two case-control studies within French Canadian population. Endocr Relat Cancer, 15, 975-83.
DOI
|
44 |
Tang C, Chen N, Wu M, et al (2009). FokI polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysis. Breast Cancer Res Treat, 117, 391-9.
DOI
|
45 |
Trabert B, Malone KE, Daling JR, et al (2007). Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case control study of Caucasian and African-American women. Breast Cancer Res, 9.
|
46 |
Uitterlinden AG, Fang Y, van Meurs JB, et al (2004). Genetics and biology of vitamin D receptor polymorphisms. Gene, 338, 143-56.
DOI
|
47 |
Wang J, He Q, Yu-guo, et al (2013). Associations between vitamin D receptor polymorphisms and breast cancer risk. Tumor Biol, 34, 3823-30.
DOI
|
48 |
Welsh J (2007). Vitamin D and prevention of breast cancer. Acta Pharmacol Sin, 28, 1373-82.
DOI
|
49 |
Yang B, Liu S, Yang X, et al (2014). Current evidence on the four polymorphisms of VDR and breast cancer risk in Caucasian women. Meta Gene, 2, 41-49.
DOI
|
50 |
Zhang K, Song L (2014). Association between Vitamin D receptor gene polymorphisms and breast cancer risk: a metaanalysis of 39 Studies. PLoS ONE, 9, 96125.
DOI
|
51 |
Zhou H, Xu C, Gu M (2009). Vitamin D receptor (VDR) gene polymorphisms and Graves' disease: a meta-analysis. Clin Endocrinol (Oxf), 70, 938-45.
DOI
|
52 |
Zinser GM, Welsh JE (2004). Accelerated mammary gland development during pregnancy and delayed postlactational involution in vitamin D3 receptor null mice. Mol Endocrinol,18, 2208-23.
DOI
|
53 |
Zmuda JM, Cauley JA, Ferell RE, et al (2000). Molecular epidemiology of vitamin D receptor gene variants. Epidemiol Rev, 22, 203-17.
DOI
|